A promising start for checkpoint inhibitors in childhood malignancies
- PMID: 31812553
- DOI: 10.1016/S1470-2045(19)30803-4
A promising start for checkpoint inhibitors in childhood malignancies
Comment on
-
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.Lancet Oncol. 2020 Jan;21(1):121-133. doi: 10.1016/S1470-2045(19)30671-0. Epub 2019 Dec 4. Lancet Oncol. 2020. PMID: 31812554 Clinical Trial.
Similar articles
-
Anti-PD-1 shows promise against advanced paediatric Hodgkin lymphoma.Lancet Oncol. 2020 Mar;21(3):e126. doi: 10.1016/S1470-2045(20)30077-2. Lancet Oncol. 2020. PMID: 32135110 No abstract available.
-
Anti-PD-1 shows promise against advanced paediatric Hodgkin lymphoma - Author's reply.Lancet Oncol. 2020 Mar;21(3):e127. doi: 10.1016/S1470-2045(20)30105-4. Lancet Oncol. 2020. PMID: 32135111 No abstract available.
-
Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma.Immunotherapy. 2016 Jun;8(6):677-9. doi: 10.2217/imt.16.6. Immunotherapy. 2016. PMID: 27197536 No abstract available.
-
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29. Clin Ther. 2015. PMID: 25823918 Free PMC article. Review.
-
Immune checkpoint inhibitors in the management of malignancies in transplant recipients.Postgrad Med J. 2018 Dec;94(1118):704-708. doi: 10.1136/postgradmedj-2018-136081. Epub 2018 Nov 13. Postgrad Med J. 2018. PMID: 30425139 Review.
Cited by
-
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.Lancet. 2024 Apr 13;403(10435):1460-1471. doi: 10.1016/S0140-6736(24)00319-2. Epub 2024 Mar 27. Lancet. 2024. PMID: 38554725 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical